The Chilean Institute of Public Health (ISP) has approved the use of the COVID-19 vaccine from the Chinese manufacturer Sinovac to immunize children from three years of age. This was reported on November 25 by the press service of the country’s Ministry of Health.
It is noted that the ISP made its decision based on the research results provided by Sinovac. According to the institute, clinical trials of CoronaVac were conducted in Chile, confirming that children tolerate the vaccine with fewer complications than adults. They also make more antibodies.
Follow the development of events in the broadcast: “Coronavirus in the world and covid certificates are all …https://mailbd.net/